Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases.


Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
12 2019
Historique:
received: 24 03 2019
revised: 22 07 2019
accepted: 22 07 2019
pubmed: 3 8 2019
medline: 21 10 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

Physical activity for women with early-stage breast cancer is well recognized for managing cancer-related symptoms and improving quality of life. While typically excluded from interventions, women with metastatic breast cancer may also benefit from physical activity. To 1) determine the safety and feasibility of a physical activity program for women with metastatic breast cancer and 2) explore the efficacy of the program. Fourteen women with metastatic breast cancer were randomized to either a control group or an 8-week home-based physical activity intervention comprising twice weekly supervised resistance training and an unsupervized walking program. The recruitment rate was 93%. Adherence to the resistance and walking components of the program was 100% and 25%, respectively. No adverse events were reported. When mean change scores from baseline to postintervention were compared, trends in favor of the exercise group over the control group were observed for the Functional Assessment of Chronic Illness Therapy-Fatigue score (+5.6 ± 3.2 vs. -1.8 ± 3.9, respectively), VO A partially supervised home-based physical activity program for women with metastatic breast cancer is feasible and safe. The dose of the resistance training component was well tolerated and achievable in this population. In contrast, adherence and compliance to the walking program were poor. Preliminary data suggest a physical activity program, comprising predominantly resistance training, may lead to improvements in physical capacity and may help women to live well with their disease.

Identifiants

pubmed: 31374368
pii: S0885-3924(19)30435-X
doi: 10.1016/j.jpainsymman.2019.07.022
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

929-939

Informations de copyright

Copyright © 2019 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Jasmine Yee (J)

Faculty of Health Sciences, The University of Sydney, Lidcombe, Australia.

Glen M Davis (GM)

Faculty of Health Sciences, The University of Sydney, Lidcombe, Australia.

Daniel Hackett (D)

Faculty of Health Sciences, The University of Sydney, Lidcombe, Australia.

Jane M Beith (JM)

The Chris O'Brien Lifehouse, Camperdown, Australia.

Nicholas Wilcken (N)

Crown Princess Mary Cancer Centre, Westmead Hospital, The University of Sydney, Lidcombe, Australia.

David Currow (D)

Faculty of Health Sciences, Flinders University, Daw Park, Australia.

Jon Emery (J)

General Practice and Primary Care Academic Centre, University of Melbourne, Parkville, Australia; General Practice, University of Western Australia, Crawley, Australia.

Jane Phillips (J)

Faculty of Health, University of Technology Sydney, Ultimo, Australia.

Andrew Martin (A)

Clinical Trials Centre, University of Sydney, Camperdown, Australia.

Rina Hui (R)

Crown Princess Mary Cancer Centre, Westmead Hospital, The University of Sydney, Lidcombe, Australia.

Michelle Harrison (M)

The Chris O'Brien Lifehouse, Camperdown, Australia.

Eva Segelov (E)

Monash Health and Monash University, Melbourne, Australia.

Sharon L Kilbreath (SL)

Faculty of Health Sciences, The University of Sydney, Lidcombe, Australia. Electronic address: sharon.kilbreath@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH